September 2007 Oncology News International

Publication
Article

Focus on Breast Cancer

ASCO studies pose question: Do brain metastases in patients with HER2+ breast ca affect overall survival?

Focus on Lung Cancer

Some long-term stablization in NSCLC with enzastaurin

Diagnostic Dilemma

Diagnostic Dilemma: GI Disease

Focus on Oncology Nursing

Nurses can administer rituximab safely by rapid infusion

Monitoring essential for heading off retinoic acid syndrome

Focus on Hematology

WT1 peptide vaccine produces durable disease control in some patients with AML or MDS; a phase II study is on the horizon

New proteasome inhibitor tested in relapsed/refractory myeloma

Phase II trial to evaluate four-drug therapy in myeloma

Focus on Colon Cancer

Loss of two hormones creates a 'recipe for colon cancer'

African Americans with proximal polyps and overweight or obese women are at higher risk for colorectal cancer: Researchers call for more screening

5T4 vaccine appears promising in metastatic colorectal ca

Focus on Prostate Cancer

Single PSA at midlife predicts advanced prostate ca risk

Cancer Care & Economics

The breast cancer HDCT/transplant debacle: Why did it happen, and could it happen again?

Recent Videos
Experts from Vanderbilt University Medical Center emphasize gathering a second opinion to determine if a tumor is resectable in patients with pancreatic cancer.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Experts from Vanderbilt University Medical Center discuss the use of intraoperative radiation therapy in a 64-year-old patient with pancreatic cancer.
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Although no responses were observed in 11 patients receiving abemaciclib monotherapy, combination therapies with abemaciclib may offer clinical benefit.
Related Content